Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Initial compound selection for sequential screening.

S Stanley Young1, Raymond L H Lam, William J Welch

  • 1GlaxoSmithKline Research Statistics Unit, 5 Moore Drive, Research Triangle Park, NC 27709, USA. ssy0487@gsk.com

Current Opinion in Drug Discovery & Development
|June 13, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Signals From Inflamed Perivascular Adipose Tissue Contribute to Small-Vessel Dysfunction in Women With Human Immunodeficiency Virus.

The Journal of infectious diseases·2024
Same author

A phase IIa active-comparator-controlled study to evaluate the efficacy and safety of efinopegdutide in patients with non-alcoholic fatty liver disease.

Journal of hepatology·2023
Same author

Continuous Conditional Generative Adversarial Networks: Novel Empirical Losses and Label Input Mechanisms.

IEEE transactions on pattern analysis and machine intelligence·2023
Same author

Assessing Methods for Evaluating the Number of Components in Non-Negative Matrix Factorization.

Mathematics (Basel, Switzerland)·2022
Same author

Activation of Nrf2 in Mice Causes Early Microvascular Cyclooxygenase-Dependent Oxidative Stress and Enhanced Contractility.

Antioxidants (Basel, Switzerland)·2022
Same author

A randomized clinical trial of the efficacy and safety of sitagliptin as initial oral therapy in youth with type 2 diabetes.

Pediatric diabetes·2021
Same journal

Microreactors for continuous processing – How close to commercial utility?

Current opinion in drug discovery & development·2010
Same journal

Synthesis of polyketide natural products and analogs as promising anticancer agents.

Current opinion in drug discovery & development·2010
Same journal

Enantioselective synthesis of substituted oxindoles and spirooxindoles with applications in drug discovery.

Current opinion in drug discovery & development·2010
Same journal

Eliminating pharmaceutical impurities: Recent advances in detection techniques.

Current opinion in drug discovery & development·2010
Same journal

Stereoselective heterocycle synthesis through oxidative carbon-hydrogen bond activation.

Current opinion in drug discovery & development·2010
Same journal

Catalysis in aqueous media for the synthesis of drug-like molecules.

Current opinion in drug discovery & development·2010
See all related articles

Selecting the right initial screening set (ISS) is crucial for efficient drug discovery. This review focuses on optimizing the ISS to improve sequential screening models and find active compounds faster.

Area of Science:

  • Drug discovery and development
  • Computational chemistry
  • Bioassay optimization

Background:

  • High-throughput screening (HTS) is a primary method for identifying drug leads.
  • Increasing numbers of targets and compounds necessitate more efficient screening processes.
  • Sequential screening offers a potential solution by iteratively refining compound selection.

Purpose of the Study:

  • To review methods for selecting the optimal initial screening set (ISS).
  • To understand how ISS characteristics impact sequential screening efficiency.
  • To enhance the identification of biologically active compounds.

Main Methods:

  • Focus on the selection strategies for the initial screening set (ISS).
  • Statistical analysis of initial compound bioassay results.

Related Experiment Videos

  • Iterative model building and compound selection for sequential screening.

    • Main Results:

    • The size and quality of the ISS significantly influence subsequent model building.
    • An optimized ISS can improve the predictive power of sequential screening models.
    • Effective ISS selection is key to enhancing the efficiency of finding active compounds.

    Conclusions:

    • The selection of the initial screening set is a critical factor in optimizing sequential screening.
    • Further research into ISS selection methodologies can accelerate drug discovery pipelines.
    • Improving ISS selection directly impacts the overall efficiency of identifying novel drug candidates.